UPDATE : Wednesday, August 12, 2020
HanAll remains positive of eye treatment’s efficacy despite initial failure by Lee Han-soo 2020-01-21 15:12
SK Biopharma’s US partner gets EMA nod for sleepiness treatment by Lee Han-soo 2020-01-21 14:22
Some Merck Korea workers commute from provinces to Seoul every day by Kim Yun-mi 2020-01-21 14:21
Daewoong’s Jeuveau sold ₩40 billion in US in 8 months by Jeong Sae-im 2020-01-21 11:43
CoImmune acquires Formula Pharmaceuticals by Lee Han-soo 2020-01-20 15:45
Pfizer’s spinoff of generics unit causes disputes with trade union by Kim Yun-mi 2020-01-20 15:44
Korea’s botulinum toxin exports hit record high in 2019 by Jeong Sae-im 2020-01-20 11:38
Takeda’s Kynteles expands indication for ulcerative colitis, Crohn’s disease by Kim Yun-mi 2020-01-17 17:30
GenScript to market Genopis' GMP-grade plasmid DNA by Lee Han-soo 2020-01-17 17:28
AbbVie says its psoriasis drug superior to Novartis’ treatment by Lee Han-soo 2020-01-17 17:28
HanAll, Daewoong unveil P3 topline results for dry eye treatment by Lee Han-soo 2020-01-16 15:46
Genome to conduct immunotherapy combo trial with Merck, Pfizer by Lee Han-soo 2020-01-16 14:47
GSK to target ovarian cancer, multiple myeloma, endometrial cancer by Kim Yun-mi 2020-01-16 14:10
Sweden prolongs financial support for IVI’s vaccine development by Lee Han-soo 2020-01-16 10:45
Pharmaceutical association lays out plans for 2020 by Lee Han-soo 2020-01-15 14:29
AptaBio attending J.P. Morgan event for global collaboration by Shim Hyun-tai 2020-01-15 13:06
GC Pharma's US offshoot opens new plasma center by Shim Hyun-tai 2020-01-15 13:05
Jeil, Oncocross to discover new indications for stroke therapy by Lee Han-soo 2020-01-15 11:31
Will Steglatro prove SGLT-2 inhibitor’s cardiovascular benefits? by Kim Yun-mi 2020-01-14 15:28
Genexine becomes largest shareholder of GenNBio by Lee Han-soo 2020-01-14 11:11
Back to Top